Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

Clinical trial NCT06641414 · RECRUITING

Trial details

NCT number: NCT06641414
Sponsor: Ascentage Pharma Group Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Higher-risk Myelodysplastic Syndrome

Start date: 2025-01-22
Primary completion: 2029-06-01
Enrollment: 490

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.